Want to see SKIN full AI Analyst Report?
SKIN Stock Chart & Stats
$0.68
$0.06(7.89%)
At close: 4:00 PM EDT
$0.68
$0.06(7.89%)
Day’s Range― - ―
52-Week Range$0.55 - $2.69
Previous CloseN/A
Volume298.38K
Average Volume (3M)543.11K
Market Cap
$92.00M
Enterprise Value$250.71
Total Cash (Recent Filing)$206.10M
Total Debt (Recent Filing)$367.10M
Price to Earnings (P/E)―
Beta1.76
Next Earnings
Nov 10, 2026EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding130,140,760
10 Day Avg. Volume433,631
30 Day Avg. Volume543,108
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)2.88
Price to Sales (P/S)0.58
P/FCF Ratio5.43
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$0.97Price Target Upside42.16% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)-0.16
Revenue Forecast (FY)$285.68M
Bulls Say, Bears Say
Bulls Say
Installed Base And Recurring RevenueA growing installed base supports repeat consumables demand and deepens provider relationships. The high recurring-revenue mix can improve visibility and customer lifetime value as utilization and treatment adoption expand.
Margin And EBITDA ImprovementMaterial gross-margin expansion and EBITDA outperformance indicate that operational efficiencies, lower equipment costs and mix benefits are taking hold. If sustained, these gains can support a more profitable model despite uneven revenue growth.
Product Pipeline And Market AccessRental financing can lower providers’ upfront investment barrier and broaden the addressable customer base. Continued product development and clinically validated boosters also provide avenues to increase treatment frequency, consumables usage and platform relevance.
Bears Say
Top-Line And Equipment Demand WeaknessLower equipment placements suggest providers remain cautious about capital spending, which can slow installed-base expansion and future consumables growth. Continued weakness across product lines raises execution risk and limits operating leverage.
High Leverage And Convertible MaturityThe aggressive capital structure leaves limited balance-sheet flexibility if operating performance deteriorates. The sizable convertible maturity creates refinancing or liquidity pressure and may constrain investment in growth, products and commercial execution.
Persistent Losses And Volatile Cash GenerationThe company has not yet converted revenue and gross-margin strength into durable net profitability. Positive cash generation is encouraging, but its sharp decline indicates volatility that could weaken debt-service capacity and reduce funding for strategic initiatives.
Beauty Health News
SKIN FAQ
What was Beauty Health’s price range in the past 12 months?
Beauty Health lowest stock price was $0.55 and its highest was $2.69 in the past 12 months.
What is Beauty Health’s market cap?
Beauty Health’s market cap is $92.00M.
When is Beauty Health’s upcoming earnings report date?
Beauty Health’s upcoming earnings report date is Nov 10, 2026 which is in 67 days.
How were Beauty Health’s earnings last quarter?
Beauty Health released its earnings results on Aug 06, 2026. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.025 by $0.005.
Is Beauty Health overvalued?
According to Wall Street analysts Beauty Health’s price is currently Undervalued.
Does Beauty Health pay dividends?
Beauty Health does not currently pay dividends.
What is Beauty Health’s EPS estimate?
Beauty Health’s EPS estimate is -0.06.
How many shares outstanding does Beauty Health have?
Beauty Health has 130,140,760 shares outstanding.
What happened to Beauty Health’s price movement after its last earnings report?
Beauty Health reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.025. Following the earnings report the stock price went down -13.82%.
Which hedge fund is a major shareholder of Beauty Health?
Currently, no hedge funds are holding shares in SKIN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.97 (42.16% Upside)
$0.97 (42.16% Upside)
Blogger Sentiment
Neutral
SKIN Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 3.3M Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.15%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.14%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Beauty Health
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
SKIN Company Deck
SKIN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: strong margin improvement, adjusted EBITDA upside and tangible strategic progress (rental program, product pipeline, installed‑base monetization) are positive. However, meaningful top‑line weakness — driven by an 18.4% decline in equipment revenue, continued consumables softness, regional softness in EMEA, and near‑term balance sheet and Nasdaq listing risks — tempers the outlook. Management is focused on execution and long‑term investments, but near‑term revenue and capital markets pressures balance the positives.View all SKIN earnings summariesSKIN Stock 12 Month Forecast
Average Price Target
$0.97
▲(42.16% Upside)
Technical Analysis
Ownership Overview
7.84% Insiders
11.07% Mutual Funds
22.11% Other Institutional Investors
55.89% Public Companies and
Individual Investors